| Withdrawn | A Clinical Study Investigating the Therapeutic Effects and Safety of an Investigational Cell Therapy Given Wit NCT06940804 | BioNTech SE | Phase 2 |
| Completed | Studying Biomarkers in Samples From Younger Patients With Malignant Germ Cell Tumor Progression NCT01433224 | Children's Oncology Group | — |
| Unknown | High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Metastatic Germ Cell Tumors That Hav NCT01172912 | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Phase 2 |
| Terminated | Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Mali NCT00788125 | City of Hope Medical Center | Phase 1 / Phase 2 |
| Completed | Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ C NCT00716976 | Children's Oncology Group | Phase 3 |
| Completed | Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatme NCT00453310 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors NCT00470366 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Unknown | Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastati NCT00551122 | University of Southampton | Phase 1 / Phase 2 |
| Completed | Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With NCT00423852 | Memorial Sloan Kettering Cancer Center | Phase 1 / Phase 2 |
| Unknown | Treatment Outcome and Quality of Life in Patients With Pediatric Extra-Cranial Germ Cell Tumors Previously Tre NCT00436774 | Children's Cancer and Leukaemia Group | — |
| Completed | Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors NCT00313599 | University of California, San Francisco | Phase 1 |
| Completed | Combination Chemotherapy in Treating Male Patients With Germ Cell Tumors NCT00301782 | Medical Research Council | Phase 2 |
| Unknown | Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracrani NCT00274950 | Children's Cancer and Leukaemia Group | Phase 3 |
| Completed | Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagno NCT00040911 | Children's Oncology Group | N/A |
| Completed | Combination Chemotherapy and Pegfilgrastim in Treating Men With Metastatic Germ Cell Tumors NCT00453232 | Cambridge University Hospitals NHS Foundation Trust | Phase 2 |
| Completed | Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors NCT00066482 | Children's Oncology Group | N/A |
| Terminated | Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Re NCT00072215 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Completed | Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors NCT00104676 | UNICANCER | Phase 3 |
| Completed | Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors NCT00070096 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Arsenic Trioxide in Treating Men With Germ Cell Cancer NCT00036842 | SWOG Cancer Research Network | Phase 2 |
| Completed | ABT-751 in Treating Young Patients With Refractory Solid Tumors NCT00036959 | National Institutes of Health Clinical Center (CC) | Phase 1 |
| Completed | Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy NCT00030108 | National Institutes of Health Clinical Center (CC) | Phase 1 |
| Completed | Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors NCT00024258 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors NCT00020150 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors NCT00003811 | Children's Oncology Group | Phase 2 |
| Completed | Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma NCT00005590 | Cancer Research Campaign Clinical Trials Centre | Phase 3 |
| Unknown | Combination Chemotherapy in Treating Men With Germ Cell Cancer NCT00003643 | European Organisation for Research and Treatment of Cancer - EORTC | Phase 2 / Phase 3 |
| Completed | High-dose ICE With Amifostine NCT00003657 | Dana-Farber Cancer Institute | Phase 2 |
| Terminated | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors NCT00003852 | UNICANCER | Phase 2 |
| Completed | High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors NCT00003173 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors NCT00007813 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 1 |
| Completed | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cel NCT00002931 | City of Hope Medical Center | Phase 2 |
| Completed | Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer NCT00002903 | European Organisation for Research and Treatment of Cancer - EORTC | Phase 2 |
| Completed | Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreat NCT00002596 | Memorial Sloan Kettering Cancer Center | Phase 3 |
| Completed | Combination Chemotherapy With Bone Marrow Transplantation in Treating Men With Germ Cell Tumors NCT00002566 | UNICANCER | Phase 3 |
| Completed | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors NCT00002558 | Memorial Sloan Kettering Cancer Center | Phase 1 / Phase 2 |
| Completed | Carboplatin, Etoposide, Cyclophosphamide, and Autologous Bone Marrow Transplantation in Patients With Relapsed NCT00002943 | Wake Forest University Health Sciences | Phase 2 |
| Completed | Melphalan in Patients With Neoplastic Meningitis NCT00002750 | Duke University | Phase 1 |
| Completed | Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer NCT00002515 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer NCT00002485 | Children's Oncology Group | — |
| Completed | Combination Chemotherapy in Treating Children With Non-testicular Malignant Germ Cell Tumors NCT00002489 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Cisplatin and Etoposide Prior to Radiation Therapy in Treating Patients With CNS Tumors NCT00002472 | Mayo Clinic | Phase 2 |
| Completed | Combination Chemotherapy Followed by Bone Marrow or Stem Cell Transplantation in Treating Patients With Relaps NCT00002508 | Temple University | Phase 1 / Phase 2 |
| Unknown | Etoposide, Carboplatin, and Bleomycin in Treating Young Patients Undergoing Surgery For Malignant Germ Cell Tu NCT00276718 | Children's Cancer and Leukaemia Group | N/A |